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PNeuropeptide Y1 Receptor NPY1R
Discovery of Naturally Occurring Human Genetic
Variants Governing Gene Expression In Cella as Well as
Pleiotropic Effects on Autonomic Activity and Blood Pressure In Vivo
Lei Wang, MD,* Fangwen Rao, MD,* Kuixing Zhang, MD, PHD,* Manjula Mahata, PHD,*
Juan L. Rodriguez-Flores, PHD,* Maple M. Fung, MD,*‡ Jill Waalen, MD,§
Myles G. Cockburn, PHD, Bruce A. Hamilton, PHD,* Sushil K. Mahata, PHD,*‡
Daniel T. O’Connor, MD*†‡
San Diego, La Jolla, and Los Angeles, California
Objectives We asked whether naturally occurring genetic variation at the human NPY1R locus alters autonomic traits that
might predispose individuals to cardiovascular disease.
Background Neuropeptide Y (NPY) interacts with the Y1 receptor, NPY1R, to control adrenergic activity and blood pressure (BP).
Methods We searched for polymorphism at NPY1R by systematic resequencing in ethnically diverse people. There were
376 twins/siblings who were evaluated for heritable autonomic traits: baroreflex function and pressor response
to environmental stress.
Results The common NPY1R variant A1050G in the 3=-untranslated region (3=-UTR) predicted baroreceptor slope (p 
0.014–0.047) and BP change to cold stress (p  0.0091–0.016), with minor allele homozygotes displaying
blunted slope and exaggerated pressor response. In 936 individuals with the most extreme BPs in the popula-
tion, not only 3=-UTR A1050G (p  1.2  104) but also promoter A-585T (p  0.001) affected both systolic
BP and diastolic BP, in interactive fashion (p  0.007), with combined homozygotes showing the highest dia-
stolic BP (20 mm Hg). The 3=-UTR variant 1050G decreased expression of a transfected luciferase reporter/
NPY1R 3=-UTR plasmid; promoter variant A-585 also decreased expression of an NPY1R promoter/luciferase
reporter. Thus, alleles that increased BP in vivo (3=-UTR 1050G, promoter A-585) also decreased NPY1R ex-
pression in cella. Computational alignment showed that A1050G disrupted a microRNA motif.
Conclusions Our results indicate that naturally occurring genetic variation at the NPY1R locus has implications for heritable
autonomic control of the circulation, and ultimately, for systemic hypertension. The findings suggest novel patho-
physiological links between the NPY1R locus, autonomic activity, and blood pressure, and suggest new strate-
gies to approach the mechanism, diagnosis, and treatment of systemic hypertension. (J Am Coll Cardiol 2009;
54:944–54) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.05.035a
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Gystemic hypertension is a common though complex trait
hat displays heritable alterations in autonomic control of
he circulation (1,2). Neuropeptide Y (NPY) is a sympa-
hetic cotransmitter along with catecholamines (3); NPY
ccounts for a unique spectrum of physiological actions in
oth the central and peripheral nervous systems, including
ardiovascular homeostasis (4), hormone secretion (5),
lood pressure (BP) (6), the stress response, emotion (7),
rom the Departments of *Medicine and †Pharmacology, University of California at
an Diego, and the ‡VA San Diego Healthcare System, San Diego, California; the
Department of Molecular and Experimental Medicine, The Scripps Research
nstitute, La Jolla, California; and the Department of Preventive Medicine, USC
eck School of Medicine, Los Angeles, California. Dr. Wang’s current address:nstitutes of Biomedical Science, Fudan University, Shanghai, China. This work was
upported by the Department of Veterans Affairs, National Institutes of Health. and feeding behavior (8). The NPY receptor family has
everal members; in contrast to the Y2, Y4, Y5, and Y6
eceptor isoforms, the Y1 receptor (NPY1R) preferentially
inds NPY. The gene encoding the NPY1R G-protein
oupled receptor is located on chromosome 4q31.3-q32 (9).
NPY acts in the periphery, via the NPY1R receptor, to
xert a vasoconstrictor/pressor effect (10); by contrast, NPY/
PY1R actions in the central nervous system may be
he authors have received support from NIH/NHLBI (HL58120) and the NIH/
CMHD-sponsored (MD000220) EXPORT/CRCHD minority health center, as
ell as the NIH/NCRR-sponsored (RR00827) General Clinical Research Center.
rs. Wang and Rao contributed equally to this work. Michael Weber, MD acted as
uest Editor for this paper.
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September 1, 2009:944–54 NPY1R Gene Expression and Hypertensionntihypertensive (6). Rodents transgenic for NPY overex-
ression display blunted BP elevations after central nitric
xide synthase inhibition, a phenomenon that can be
eversed centrally by the selective Y1 receptor antagonist
IBP3226 (6). In addition, NPY1R knockout mice display
rofound changes in adrenergic activity, with increased
atecholamine biosynthesis and secretion (11). However,
he role of NPY1R variation in human BP regulation
emains unexplored.
Considering the potential effects of NPY1R variation on
uman BP, we hypothesized that human genetic variation
t NPY1R may result in quantitative or qualitative changes
n NPY1R activity, in turn influencing NPY signaling so as
o alter autonomic activity and perhaps predispose to car-
iovascular disease. We therefore explored natural allelic
ariation at the NPY1R locus by resequencing the gene in 80
thnically diverse subjects (2n  160 chromosomes). We
hen explored the role of NPY1R genetic variation in human
hysiology, with a twin cohort extensively phenotyped for
utonomic activity as well as disease, using a sample of
ndividuals with the most extreme BPs in the population.
inally, we characterized the functional activity of 2 disease-
ssociated variants in the 3=-untranslated region (UTR) and
roximal promoter.
ethods
ubjects and clinical characterization. POLYMORPHISM DIS-
OVERY AND BIOGEOGRAPHIC ANCESTRY. Initially, 80 in-
ividuals (2n  160 chromosomes) were studied by rese-
uencing of NPY1R for systematic polymorphism discovery:
0 individuals were of European ancestry (white), 20 were
f sub-Saharan African ancestry (black), 20 were of Asian
ncestry, and 20 were of Hispanic ancestry. Ethnicity was
stablished by self-identification by the participants as well
s their parents and grandparents. None of the subjects had
history of renal failure. Definitions of subject characteris-
ics are according to previous reports from our laboratory
12). Subjects were volunteers from southern California,
nd each subject gave informed and written consent; the
rotocol was approved by the University of California San
iego Institutional Review Board.
WIN/SIBLING SAMPLE. We recruited a series of twin pairs
nd siblings (n  376), taking advantage of a large
opulation-based twin registry in southern California
13,14) and newspaper advertising (14). These twin indi-
iduals were all of European ancestry to permit allelic
ssociation studies within 1 ethnicity. There were 360 twin
ndividuals from 180 white (European ancestry) twin pairs,
ncluding 125 monozygotic pairs and 55 dizygotic pairs.
he twin/sibling subjects were 14 to 84 years old.
YPERTENSION. We studied 936 (404 male, 532 female)
hite (European ancestry) subjects, recruited from a large
rimary care (Kaiser Permanente) population in San Diego, as
reviously described (15). In this primary care population, Ppproximately 81% attended the
linic, and approximately 46%
onsented to participation in the
tudy, with collection of blood for
reparation of genomic deoxyribo-
ucleic acid (DNA). From con-
enting participants, the subjects in
his study were selected, based
pon measurement of diastolic
lood pressure (DBP), to represent
he highest and lowest fifths of
iastolic BP percentiles in that
opulation. There were 426 sub-
ects chosen for higher DBPs; 510
ubjects were chosen for lower
BPs. The DBP criterion was
hosen because of its heritability
13). The statistical power of asso-
iation between biallelic DNA
arkers and human quantitative
rait loci can be substantially aug-
ented by sampling individuals from opposite (upper and
ower) ends of the trait distribution (16–18), and analyses of
he quantitative trait in extreme subjects (as opposed to
ichotomization of the trait) further enhances power (19). This
opulation sample afforded us90% power to detect genotype
ssociation with a trait when the genotype contributes as little
s 2.5% to the total variation in males (even at p  108); the
ower is even higher in females. To accomplish this, individ-
als with lower BP (systolic blood pressure [SBP]/DBP 
08  0.7/56  0.2 mm Hg) were selected from the bottom
.8th percentiles of DBP; the higher BP group (SBP/DBP 
54  0.8/99  0.3 mm Hg) was selected from the top 4.9th
ercentiles of DBP. Both SBP and DBP differed significantly
etween the BP extreme groups (p  0.0001). Although
mbulatory BP monitoring would increase the accuracy of BP
iagnosis and provide superior prediction of target organ
amage (20), the very large epidemiologic scale of this primary
are-based ascertainment precluded its use here. Forty-one
ercent of patients in the higher BP group were taking 1 or
ore antihypertensive medications (including 15% on diuretics
nd 19% on angiotensin-converting enzyme [ACE] inhibi-
ors), and no patients in the lower BP group were on such
reatment. In subsequent analyses, BP results were also ad-
usted for the effects of antihypertensive treatment by adding a
xed value (10/5 mm Hg) to each treated BP, as described
21). Although such adjustments are necessarily imperfect,
heir value is reinforced by restoration of familial (sibling/
ibling) BP correlations (21); alternative adjustments based on
pecific medication categories (22) were not used.
enomics. SYSTEMATIC POLYMORPHISM DISCOVERY BY
ESEQUENCING. Genomic DNA was prepared from leuko-
ytes in ethylenediaminetetraacetic acid-anticoagulated
lood, using PureGene extraction columns (Gentra, Qia-
en, Valencia, California) as described previously (23).
Abbreviations
and Acronyms
BP  blood pressure
DBP  diastolic blood
pressure
Del  deletion
h2  heritability
HR  heart rate
Ins  insertion
LD  linkage disequilibrium
NPY  neuropeptide Y
NPY1R  neuropeptide Y1
receptor
SBP  systolic blood
pressure
SNP  single nucleotide
polymorphism
UTR  untranslated regionublic draft human genome sequences were obtained from
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NPY1R Gene Expression and Hypertension September 1, 2009:944–54he University of California, Santa Cruz Genome Bio-
nformatics Website and used as a scaffold for primer de-
ign. The base position numbers were from the National
enter for Biotechnology Information NPY1R source clones
M_000909, NT_016354, and NP_000900. Promoter posi-
ions were numbered with upstream of (–) the NPY1R exon 1
tart (cap) site. The following polymerase chain reaction
rimers were designed by primer 3 (19) to span approximately
,000 bp of the proximal promoter and each of the 3 exons.
romoter 1, left primer 5=-ggcagtgccctgtatcttta-3=, right
rimer 5=-tgccactgtgcttttctttg-3=; promoter 2, left primer 5=-
ccattattgtggcgaattt-3=, right primer 5=-tcgtttttcttcccctctca-3=;
xon 1, left primer 5=-cagtatgttttcaccatttctgc-3=, right primer
=-acagcaaggacccaaatcac-3=; exon 2, left primer 5=-
gagggtggagaccaaataa-3=, right primer 5=-catcgtggacatggc-
attg-3=; exon 3-1, left primer 5=-ccacgatgcacacagatgtt-3=, right
rimer 5=-tgacaatcagttgggagcaa-3=; exon 3-2, left primer 5=-
gaagtggtttgaggtttct-3=, right primer 5=-gaaaaagcaaaaac-
atattg-3=.
Target sequences were amplified by polymerase chain
eaction from 20 ng genomic DNA in a final volume of 25
l, which also contained 0.1 U of Taq DNA polymerase
Applied Biosystems, Foster City, California), 200 nM of
ach dNTP, 300 nM of each primer, 50 mM KCl, and 2
M MgCl2. Polymerase chain reaction was performed in
n MJ PTC-225 thermal cycler, starting with 12 min of
enaturation at 95°C, followed by 45 cycles at 95°C for 30 s,
3°C for 1 min (annealing), 72°C (extension) for 1 min, and
hen a final extension of 8 min at 72°C. Polymerase chain
eaction products were treated with exonuclease I and
hrimp alkaline phosphatase to remove primers and then
NTPs before cycle sequencing with BigDye terminators
Applied Biosystems). Sequence was determined on an
BI-3100 automated sequencer. Polymorphism and het-
rozygosity were detected using a CodonCode Aligner
CodonCode Corp., Dedham, Massachusetts).
INGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING.
enotypes were determined by 2 extension-based techniques,
ither the MALDI (matrix assisted laser desorption ioniza-
ion) mass spectrometry method of Sequenom (San Diego,
alifornia), or the luminescent base incorporation method
f Pyrosequencing (Biotage, Uppsala, Sweden), in which
enotypes were verified by visual inspection, with exclusion
f artifactual data from further analysis. Reproducibility of
iploid genotypes was verified with blinded replicate sam-
les, indicating 98.8% concordance.
hysiological/autonomic phenotyping in vivo. Noninva-
ive brachial arterial cuff BPs were obtained in seated
ubjects with an oscillometric device, as previously described
24). To probe autonomic control of the circulation in twin
airs, BP and heart rate were recorded continuously and
oninvasively for 5 min in seated, resting subjects with a
adial artery applanation device as well as thoracic electro-
ardiogram electrodes and dedicated sensor hardware (Colin
ilot, Colin Instruments, San Antonio, Texas) and software gATLAS, WR Medical Electronics Co., Stillwater, Min-
esota; and Autonomic Nervous System, Tonometric Data
nalysis [ANS-TDA], Colin Instruments). Baroreceptor
lope and heart rate variability were quantified as previously
escribed (25). The BP and heart rate responses to envi-
onmental (cold) stress (1 hand immersed in ice water for 1
in) were obtained with the same hardware and software, as
reviously described (25).
PY1R variants (promoterA-585T, and 3=-UTRA1050G):
unctional consequences in cella. 3=-UTR. The 1338 bp 3=-
TR was amplified with polymerase chain reaction primers
ncorporating XbaI restriction sites, facilitating ligation into
he unique XbaI site in the luciferase reporter plasmid
GL3-Promoter (Promega, Madison, Wisconsin); in this
lasmid, the XbaI site is just downstream (3=) of the firefly
uciferase reporter open reading frame and upstream of the
olyadenylation signal (pA from SV40). Transcription is
riven by the SV40 early promoter, just upstream (5=) of the
uciferase cassette. Correct orientation (5= to 3=) of the insert
as verified by sequencing.
ROMOTER. The 1101 bp promoter region was amplified
ith polymerase chain reaction primers incorporating NheI
nd HindIII restriction sites, facilitating ligation into the
uciferase reporter plasmid pGL3-Basic (Promega). The
nsert was verified by sequencing.
UTAGENESIS AND TRANSFECTION. Creation of the
1050G or A-585T polymorphisms was achieved by
ite-directed mutagenesis (QuikChange, Stratagene, La
olla, California). After plasmid growth under ampicillin
election in E. coli and purification on columns (Qiagen),
upercoiled plasmid DNA was transfected into PC12 chro-
affin cells using established protocols and Superfect cat-
onic lipid reagent (Qiagen), along with the transfection
fficiency control plasmid p-cytomegalovirus-beta-Gal, en-
oding the beta-galactosidase reporter plasmid under con-
rol of the cytomegalovirus promoter (Promega). After
ransfection and cell growth over an 8- to 24-h time course,
ells were lysed for sequential measurement of luciferase
nzymatic activity and beta-galactosidase expression.
tatistical genetics. DESCRIPTIVE STATISTICS. Descrip-
ive statistics (mean, SEM) were computed across all twins,
sing generalized estimating equations (PROC GENMOD)
n Statistical Analysis System (SAS Institute, Cary, North
arolina). Population BP extreme analyses were performed
y 2-way analysis of variance in the Statistical Package for the
ocial Sciences (SPSS Inc., Chicago, Illinois).
eritability of phenotype expression in vivo. Heritability
h2) is the fraction of phenotypic variance accounted for by
enetic variance (h2  VG/VP). Estimates of h
2 were
btained using the variance component method imple-
ented in the Sequential Oligogenic Linkage Analysis
outine (SOLAR) package (26). This method maximizes
he likelihood of the estimate assuming a multivariate
ormal distribution of phenotypes in twin pairs (monozy-
otic vs. dizygotic) with a mean dependent on a particular
s
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September 1, 2009:944–54 NPY1R Gene Expression and Hypertensionet of explanatory covariates. The null hypothesis (H0) of no
eritability (h2  0) is tested by comparing the full model,
hich assumes genetic variation, and a reduced model,
hich assumes no genetic variation, using a likelihood ratio
est. Covariates (sex and age) that were significant at p 
.05 were retained in the heritability model. Before analyses
n the Sequential Oligogenic Linkage Analysis Routine,
xploratory descriptive statistics were computed for each
rait, and if trait values displayed excessive kurtosis, they
ere log10-transformed to achieve kurtosis less than 0.8.
aplotypes and linkage disequilibrium (LD). After rese-
uencing, we constructed LD maps by using 4 common
NPs (minor allele frequencies 10%). Blocks of LD were
isplayed using Haploview (27), using the 4-gamete rule,
nd displaying pairwise results as r2. Haplotypes constructed
y A1050G (3=-UTR) and A-585T (promoter) were
nferred by the HAP algorithm (28).
arker-on-trait association. During associations at
1050G and A-585T (or their haplotypes), subjects were
ategorized according to either diploid genotype at a bial-
elic SNP locus, or carrier status (2, 1, or 0 copies) for a
articular haplotype. When more than 1 SNP within an LD
lock was associated with a trait, the software SNPSpD (29)
as used to yield new experiment-wide thresholds to
aintain the type I error rate at 5%.
NP-by-SNP interaction. We tested the interaction be-
ween A1050G and A-585T by 2-way analysis of variance
n SPSS. Diastolic BP value was taken as the dependent
ariable; both of the SNPs were categorized as fixed factors.
ovariates were age and sex.
ioinformatics. Multiple sequence alignments across spe-
ies were conducted in Clustal-W http://www.ebi.ac.uk/
Figure 1 NPY1R Resequencing Strategy and Identified Variants
Sequences conserved between mouse and human neuropeptide Y1 receptors (NPY
of common (minor allele frequency 5%) and rare single nucleotide polymorphism
scriptional initiation (exon 1) start site. Solid blocks  open reading frame; hatchools/clustalw2/index.html. 3=-UTR microRNA motifs
ere predicted at http://www.microrna.org/microrna/
etGeneForm.do or at RegRNA http://bidlab.life.nctu.
du.tw/RegRNA2/website/. Ribonucleic acid (RNA) hy-
rid structures and predicted minimum folding energies
ere analyzed at http://bibiserv.techfak.uni-bielefeld.de/
nahybrid/submission.html. RNA folding algorithms (http://
ww.genebee.msu.su/service/rna2_reduced.html) predicted
olding free energy difference between wild-type and variant, as
ell as messenger ribonucleic acid (mRNA) stem/loop
tructures.
esults
ystematic human polymorphism discovery at NPY1R. To
dentify genetic variants in NPY1R, we resequenced both
xons and adjacent regions, 1 kbp of 5= promoter region,
nd the UTRs in DNA from 80 human subjects (2n  160
hromosomes) from 4 biogeographic ancestry groups:
sian, Hispanic, black, and white. Figure 1 and on-line
able 1 illustrate the strategy. Altogether, 12 biallelic SNPs
nd 1 (4-bp) insertion/deletion were identified. Among the
2 SNPs, 7 were located within the 1 kbp proximal
romoter, 1 in the 5=-UTR, 1 in the coding region, and 3 in
he UTRs. Four variants were common (minor allele fre-
uency 5%): 2 SNPs and the insertion/deletion (Ins/Del)
n the promoter, and 2 in the 3=-UTR.
SNP genotype frequencies differed substantially by eth-
icity (Online Table 1): Promoter T-674G occurred only in
he black and Hispanic groups. The 3=-UTR T601C was
n unusual variant in Hispanics, but it was substantially
ore common in the other 3 groups. Although A-585T,
ere visualized with Windows VISTA (Microsoft, Redmond, Washington). Locations
s) are indicated. Positions are numbered upstream or downstream of the tran-
cks  untranslated regions (UTRs). PCR  polymerase chain reaction.1R) w
s (SNP
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NPY1R Gene Expression and Hypertension September 1, 2009:944–54ATTT/-] –464 Ins/Del, and A8344G (within the 3=-
TR; A1050G) were common in all 4 ethnic groups,
heir frequencies differed among the groups.
inkage disequilibrium (LD) across the NPY1R locus. Pair-
ise LD among 4 common SNPs and the Ins/Del across
PY1R was qualified as parameter r2, scaled from 0 to 1.
nline Figure 1 shows the LD and haplotype block struc-
ure in 4 different ethnic groups. In the promoter,
ATTT/-] 464 Ins/Del and A-585T were in complete LD
n whites and Asians, and strong LD in blacks and Hispanics.
n Asians, the 4 common polymorphisms were located within
single LD block (by the 4-gamete rule in Haploview);
dditional blocks are apparent in the other groups.
utonomic trait heritability (h2) in twins. Heritability
Table 1) was significant for several autonomic traits, such
s the hemodynamic response to environmental (cold)
tress, including initial SBP (h2  40.7  7.3%, p 
.0001), initial DBP (h2  28.7  8.6%, p  0.001), final
BP (h2 28.3 7.9%, p 0.0004), final DBP (h2 30.1
.8%, p  0.0001), DBP change (h2  26.7  8.5%, p 
.0014), and SBP change (h2  19.8  9.7%, p  0.023).
eritability was also significant for baroreceptor coupling in
he low frequency domain (0.05 to 0.15 Hz; h2  52.6 
.9%, p  0.0001), high frequency domain (0.15 to 0.4 Hz;
2 41.2  7.5%, p  0.0001), and for baroreceptor slope,
oth upward deflections (h2  25.8  10.5%, p  0.009),
nd downward deflections (h2 38.6 7.2%, p 0.0001).
PY1R variant association with autonomic traits in
wins. We began by testing whether the NPY1R genetic
ariation affected physiological traits in twins. Since the
umber of LD blocks was limited (Online Fig. 1), we chose
common SNPs to “tag” the locus: promoter/A-585T and
=-UTR/A1050G. The 3=-UTR variant A1050G pre-
icted several physiological traits whose alterations are
eritability (h2) and Effects of NPY1R 3=-UTR Variant A1050G onTable 1 Heritability (h2) and Effects of NPY1R 3=-UTR Variant A
Heritability (h2)
(360 Twins)
Phenotype %  SEM p Va
Baroreceptor coupling (frequency domain), ms/mm Hg
At 0.15–0.40 Hz (high frequency) 41.2 0.08 <0.0
At 0.05–0.15 Hz (low frequency) 52.6 0.06 <0.0
Baroreceptor slope (time domain), ms/mm Hg
Upward deflections 25.8 0.10 0.0
Downward deflections 38.6 0.07 <0.0
Cold stress response, mm Hg
Initial SBP 40.7 0.07 <0.0
Initial DBP 28.7 0.09 0.0
Final SBP 28.3 0.08 <0.0
Final DBP 30.1 0.08 <0.0
Change in SBP 19.8 0.10 0.0
Change in DBP 26.7 0.09 0.0
alues of h2 are mean % SEM, where h2 is the % of phenotypic variation (VP) explained by addit
nalysis Routine (SOLAR), and expressed as %. The p value is the significance of the heritability v
rom generalized estimating equations (PROC GENMOD) in SAS, to account for correlations within
DBP  diastolic blood pressure; NPYIR  neuropeptide Y1 receptor; SBP  systolic blood pressnvolved in the pathogenesis of hypertension (1). aARORECEPTOR MECHANISM. The baroreceptor system ex-
rts second-to-second feedback control over blood pressure
omeostasis, and baroreceptor defects may precede hyper-
ension, as early “intermediate phenotypes” (1). The 3=-
TR variant predicted baroreceptor slope, during both
pward deflections (p  0.014) and downward deflections
p  0.037). 3=-UTR A1050G also predicted beat-to-
eat baroreflex coupling, in both the high frequency (0.15 to
.40 Hz, p  0.015) and low frequency (0.05 to 0.15 Hz,
 0.047) domains (Table 1).
RESSOR RESPONSE TO ENVIRONMENTAL (COLD) STRESS.
ongitudinal studies of the BP response to cold stress (cold
ressor test) indicate that change in BP may predict future
evelopment of hypertension (30). Significant prediction by
1050G was observed for not only final (post-cold) DBP
p 0.0095), but also for SBP (p 0.0091) and DBP (p
.016) changes during cold stress.
In Figure 2, the relationship between baroreceptor slope
upward deflections) and SBP change to cold stress is
ortrayed in 2 dimensions. The 3=-UTR A1050G minor
llele homozygotes (G/G diploid genotype) displayed de-
reased baroreceptor slope and increased SBP change. Thus,
he G allele seems to act recessively on these traits.
Neither the promoter/A-585T nor the 3=-UTR/A1050G
ariants were associated with body mass index in twins (for
romoter/A-585T, p  0.81; for 3=-UTR/A1050G, p 
.74).
PY1R polymorphisms and hypertension. The 3=-UTR
1050G and promoter A-585T were scored in 936
ndividuals selected from the extreme upper/lower fifth
ercentiles of BP in a large primary care population (Online
able 1). Each SNP showed significant effects on both DBP
Fig. 3) (A-585T, p  1.2  104; A1050G, p  0.001)
iological Traits in Twin Siblings Pairs50G on Physiological Traits in Twin Siblings Pairs
NPY1R 3=-UTR A1050G Diploid Genotype
(376 Twins and Sibs)
A/A or A/G (n  357) G/G (n  19) Chi-Square p Value
15.7 2.0 10.2 1.8 5.90 0.015
15.1 1.2 11.5 1.5 3.97 0.047
15.0 0.6 10.8 1.4 5.99 0.014
12.5 0.6 9.7 1.2 4.33 0.037
118.9 1.1 119.8 2.9 0.11 0.739
64.6 0.8 67.6 2.0 2.11 0.146
131.1 1.5 139.2 4.0 3.29 0.069
75.5 1.0 82.5 2.1 6.72 0.0095
12.9 1.4 20.2 2.2 6.80 0.0091
10.9 0.9 15.4 1.6 5.77 0.016
etic factors (VG), in 360 twins. Values are age- and sex-adjusted in Sequential Oligogenic Linkage
ngle nucleotide polymorphism (SNP) statistics for twin and sibling study population were derived
s. Bold values indicate p  0.05.Phys10
lue
01
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2
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ive gen
alue. Sind SBP (A-585T, p  0.018; A1050G, p  0.012).
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September 1, 2009:944–54 NPY1R Gene Expression and HypertensionIn addition, there was an SNP-by-SNP interaction on
BP (SNP-by-SNP p  0.007): A1050G effects on BP
epended upon the background of A-585T genotype, with
he very highest DBP values found in subjects with com-
ined -585 A/A and 1050 G/G homozygosity. Signifi-
ance did not change after BP adjustment for treatment.
BP was also analyzed as a dichotomous trait (high vs.
ow), using both 2-way analysis of variance and regression.
n analysis of variance, BP status was influenced by
romoter A-585T (p  3.92  104), as well as 3=-UTR
1050G (p  0.005), and the interaction of the 2 (p 
.032). On regression, BP status was influenced by promoter
-585T (p 0.001) as well as 3=-UTR A1050G (p 0.030).
On 2-SNP haplotype analyses across NPY1R, Hap-4
promoter A-585 ¡ 3=-UTR 1050G) was strongly asso-
iated with both SBP and DBP (Fig. 4): subjects with 2
opies of Hap-4 displayed increases in both SBP and DBP
SBP, p  0.007; DBP, p  2.34  105). When BP was
nalyzed as a dichotomous trait (Fisher’s exact test), Hap-4
opy number affected the trait (p  2.3  104).
Although the hypertensive subjects displayed higher body mass
ndex than the normotensive group (30.6  0.3 vs. 24.6  0.2
g/m2, p  0.001) (Online Table 1), neither of the 2 NPY1R
ariants associated with body mass index in this sample
promoter/A-585T, p 0.096; 3=-UTR/A1050G, p 0.918).
tatistics: alpha threshold. We re-evaluated the alpha
hreshold required to avoid false-positive conclusions in the
etting of 2 genetic markers (3=-UTR A1050G and
romoter A-585T) by using SNPSpD (SNP SPectral De-
Figure 2
NPY1R 3=-UTR Variant A1050G:
Pleiotropic Effects on Coupling Between
Baroreceptors and Stress Response
BP  blood pressure; GEE  generalized
estimating equation; other abbreviations as in Figure 1.omposition) (29), which takes into account the correlationsmong linked markers. The effective number of markers was
omputed at 1.76, and thus the appropriate alpha threshold
ell to p  0.028. The polymorphism effects on twin traits
nd population BP exceeded even this more stringent
hreshold.
PY1R 3=-UTR A1050G and promoter A-585T:
unctional consequences in cella and interspecies se-
uence homology. 3=-UTR A1050G. Wild-type
A1050) versus variant (1050G) 1338 bp NPY1R 3=-
TRs were ligated into reporter plasmid pGL3-Promoter,
ownstream of the luciferase reporter gene. After transfec-
ion into PC12 cells, cellular luciferase activity was mea-
ured. The 2 3=-UTR plasmids had significantly different
uciferase activities in chromaffin cells, with wild-type A 
ariant G at several time points after transfection (p 
.001) (Fig. 5); the AG difference was also seen in
mbryonic kidney cells (Online Fig. 2) (p  0.001). In
eLa fibroblasts, the activities of both promoters were
iminished, though the AG difference persisted.
Promoter A-585T. Promoter A-585T was in complete
inkage disequilibrium (r2  1) with the 464[ATTT]
ns/Del in the white population: the A-585 allele appeared
onsistently with 464ATTT Ins; the 585T allele ap-
eared with 464ATTT Del. Thus, wild-type (A-585 ¡
464ATTT Ins) versus variant (585T ¡ 464ATTT
el) 1101 bp NPY1R promoter segments were ligated into
eporter plasmid pGL3-Basic, just upstream of the lucif-
rase reporter gene. We also used site-directed mutagenesis
o create all 4 possible promoter haplotypes. After transfec-
Figure 3
NPY1R Common Variants in the 3=-UTR
(A1050G) and Proximal Promoter (A-585T)
Influence BP Both Independently and Interactively
ANOVA  analysis of variance; BP  blood pressure;
DBP  diastolic blood pressure; other abbreviations as in Figure 1.
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NPY1R Gene Expression and Hypertension September 1, 2009:944–54ion into PC12 cells for 24 h, luciferase activity was
easured.
The promoter haplotypes displayed significantly different
uciferase activities (p  0.001) (Fig. 6). Between the 2
aturally occurring haplotypes, the variant (585T ¡
464ATTT Del) was 25% more active (p  0.001) than
ild-type (A-585 ¡ 464ATTT. Availability of all 4
aploytpes (both natural and artificial) allowed us to explore
he contingent actions of each variant (Fig. 6): on a
ackground of the464 Del allele,585T was more active
Figure 4
NPY1R Haplotype 4 (A-585 ¡
1050G) Is Associated With Both DBP
and SBP in a European Ancestry Population
SBP  systolic blood pressure; other abbreviations as in Figure 1.
Figure 5 NPY1R 3=-UTR Polymorphism
A1050G Influences Gene Expression In Cella
Results of luciferase reporter/3=-UTR variant
transfections into PC12 cells are shown. Abbreviations as in Figure 1.(han A-585; by contrast, on a background of the 464 Ins
llele, A-585 was more active than 585T. Thus, both
olymorphisms (A-585T and Ins-464Del) influenced tran-
criptional activity.
LIGNMENTS. Both the promoter A-585T and 3=-UTR
1050G polymorphisms lie in regions of generally con-
erved sequence across primate species (Online Figs. 3A and
B). Based on the chimpanzee sequence, the likely human
ncestral allele at A1050G is A (the most frequent allele);
t A-585T the likely ancestral allele is A (also the most
requent allele). Although the promoter region spanning
-585T was well conserved, no clear cut match was found
or any known transcriptional control motif spanning
-585T.
PY1R 3=-UTR A1050G: RNA motifs and microRNA
inding site prediction. Sequence alignment suggested that
1050G is located in a region where hsa-miR-511 interacts
Fig. 7). The RNA hybrid structure of hsa-miR-511 dif-
ered between A1050 and 1050G, as did the predicted
inimum folding energy of hsa-miR-511 hybridization.
he lower minimum folding energy of the 1050G variant
at 24.4 kcal/mol) would predict better binding of hsa-
iR-511 to the variant mRNA, and hence more efficient
egradation of the variant mRNA, a finding consistent with
ecreased reporter expression by the variant luciferase/3=-
TR plasmid (Fig. 5).
iscussion
verview. In this study, we probed whether common
enetic variation at the NPY vasoconstrictive receptor
Figure 6 Effect of NPY1R Common Promoter Variants
(A-585T and Ins/Del) on Gene Expression In Cella
Natural: Haplotype combination found in human NPY1R promoter deoxyribonucleic
acid. Del  deletion; Ins  insertion; other abbreviations as in Figure 1.NPY1R) locus might influence autonomic function and
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September 1, 2009:944–54 NPY1R Gene Expression and Hypertensionisease. We began by undertaking systematic polymor-
hisms discovery at NPY1R, revealing several novel variants
n likely functional domains, especially noncoding regions.
n a study of twin pairs characterized for heritable “inter-
ediate” phenotypes that may be precursors to hyperten-
ion, a common variant in the 3=-UTR (A1050G) was
ound to influence such traits, including baroreceptor func-
ion and the BP response to environmental stress. In
ubjects with the most extreme BP values in a large primary
are population, 3=-UTR A1050G and promoter A-585T
nteracted to determine BP. Finally, both the 3=-UTR and
romoter variants were functional in luciferase reporter
ssays. The results indicate that common functional NPY1R
olymorphisms affect NPY1R expression through both tran-
criptional and posttranscriptional mechanisms, eventuating
n alterations of autonomic function, and ultimately, in
ystemic hypertension.
PY1R distribution and functional roles. NPY exhibits
range of important physiological activities, including
ffects on psychomotor activity, central regulation of
ndocrine secretion, and potent vasoactive effects on the
ardiovascular system (31). NPY1R is the widely ex-
ressed major subtype of NPY receptor, where it medi-
tes vasoconstriction in response to peripheral NPY (32).
n the central nervous system, studies of an NPY trans-
A
B
C D
mfe: -24.4 kcal/mol
Figure 7 NPY1R 3=-UTR Variant A1050G Occurs in a Micro-R
(A, B) Complementarity between hsa-miR-511 and the NPY1R 3=-UTR site (1034–
The A1050G SNP is given in bold type. Upper case: maximal scoring alignment r
miR-155 to the NPY1R mRNA harboring the A (D) or G (C) alleles at A1050G. A
tions as in Figure 1.enic rat by Michalkiewicz et al. (6) concluded that the pentral NPY/NPY1R system provides an endogenous
echanism to reduce pressor responses; hence peripheral
nd central NPY/NPY1R responses lead to diametrically
pposite effects on BP.
Cavadas et al. (11) studied the effects of NPY1R
nockout (targeted gene ablation): NPY caused secretion
f catecholamines from primary cultures of mouse adre-
al chromaffin cells, and this release was abolished in
ultures from NPY1R knockout mice, suggesting an
mportant role of the NPY/NPY1R signaling pathway
oward catecholamine secretion. In NPY1R knockout
ice they also found increases in adrenal catecholamine
ontent, constitutive catecholamine release, and plasma
atecholamine concentrations. In Y1receptor-expressing
ells, NPY decreased the activity of tyrosine hydroxylase,
he rate-limiting enzyme in catecholamine biosynthesis
11); such effects could be prevented by the selective Y1
eceptor antagonist BIBP3226, suggesting a far-reaching
nfluence of the NPY/NPY1R system upon catechol-
mine metabolism.
ardiovascular consequences of NPY1R polymorphism:
utonomic and risk traits. NPY1R 3=-UTR A1050G
redicted several heritable (Table 1) autonomic traits that
ay be “intermediate phenotypes,” or precursors to hyper-
ension (1). In particular, 3=-UTR G/G homozygotes dis-
22.3 kcal/mol
ecognition Motif
bp downstream from the NPY1R stop codon), variant (A) versus wild-type (B).
Lowercase: not part of maximal scoring alignment region. (C, D) Hybridization of
highlight the polymorphic site. Calculated mfe minimum free energy. Abbrevia-mfe: -
NA R
1055
egion.
rrowslayed not only diminished baroreflex function (by 3 indi-
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NPY1R Gene Expression and Hypertension September 1, 2009:944–54es) (Table 1), but also increased pressor responses to stress.
iminished baroreceptor function results in an inability to
efend BP against such insults as environmental (e.g., cold)
tress, and repeated pressor responses may eventuate in
ustained or fixed BP elevation (30). Thus both barorecep-
or dysfunction and increased BP pressor responses may be
isk indicators for future development of hypertension
1,30). Of note for the Y1 receptor, NPY1R knockout mice
isplay hyperalgesia to thermal, cutaneous, and visceral
hemical stimuli (31), although their pressor responses to
old stimulation are reportedly unchanged (33).
Finally, our genetic results suggest a role for a specific
ariant, NPY1R A1050G, in triggering a pleiotropic series
f effects on cardiovascular risk (Figs. 2 to 4); furthermore,
henotypic clustering as a function of genotype for both
aroreceptor function and pressor responses indicates that
/G homozygotes cluster substantially away from other
ndividuals (Fig. 2), suggesting that the G (minor) allele
ay act recessively in this regard. The substantial frequency
f the G (minor) allele (at 25% to 50%) (Online Table 1)
llowed us to detect the G/G effect in sufficiently large
opulation samples (376 twins and siblings).
ypertension: genetic interaction. In subjects with the
ost extreme BPs in the population (Fig. 3), promoter
-585T and 3=-UTR A1050G each had substantial
ffects upon both DBP and SBP. In addition, we found that
hese 2 variants interacted significantly (p  0.007) to
etermine DBP. For example, the most dramatic elevation
f DBP occurred in subjects who were homozygotes for
oth the promoter variant major allele (A/A at A-585T)
nd the 3=-UTR variant minor allele (G/G at A1050G).
he importance of particular SNP-by-SNP combinations
as confirmed in haplotype analyses (Fig. 4), in which we
ound that Hap-4 (promoter A-585 ¡ 3=-UTR 1050G)
ad a copy number-dependent effect on both SBP (p 
.001) and DBP (p  0.001), with the most extreme effects
15/20 mm Hg SBP/DBP) in individuals who bore 2
opies of A¡G.
enetic variation: role of alterations in gene expres-
ion. In both the promoter and the 3=-UTR, hypertension-
ssociated NPY1R alleles decreased gene expression in cella,
hough by predictably different mechanisms.
=-UTR. Endogenous microRNAs mediate gene silencing by
inding to specific motifs within the 3=-UTRs of target
RNAs (34). In the human NPY1R transcript, bioinfor-
atic analyses indicated that variant A1050G is located in
motif recognized by hsa-miR-511 (Fig. 7). The RNA
ybrid structures and minimum folding energies of the
omplexes between hsa-miR-511 and the 3=-UTRs suggest
hat hypertension-associated variant 1050G participates
n a more stable complex than wild-type A1050. Such
table binding between hsa-miR-511 and 3=-UTR1050G
ay facilitate the RNA-induced silencing complex, therebyeducing NPY1R expression. SThere is emerging precedent for functional variation in
=-UTRs that may contribute to blood pressure regulation.
functional variant in the 3=-UTR of the angiotensin II
eceptor AGTR1 disrupts a microRNA binding motif (34).
e recently characterized functional variants that contrib-
te to hypertension risk in the 3=-UTRs of chromogranin A
a protein catalytic in formation of catecholamine storage
esicles) (30) and GTP cyclohydrolase (rate-limiting in
ormation of pterin cofactors) (35).
ROMOTER. In the promoter, common variants A-585T
nd Ins/Del/-464 each demonstrated functional activity in
uciferase reporter constructs (Fig. 6). Hypertension-
ssociated promoter allele 585T decreased promoter ex-
ression, whether studied in isolation (Fig. 3) or in the
ontext of its naturally occurring haplotype (Fig. 4). Al-
hough the local sequence region around A-585T is con-
erved across species (Online Fig. 3B), the precise motif in
is, and trans-acting factors, perturbed by A-585T are not
et understood.
dvantages and limitations of this study. TWIN PHENO-
YPING. We used the classical twin design in the search for
rait-associated polymorphisms (36). Multiple autonomic
henotypes were measured in the twins, which permitted
stimation of trait heritability as well as definition of effects
f particular genetic variants at NPY1R on such “interme-
iate phenotypes” (Table 1); dual documentation of herita-
ility and association lends internal consistency to the
pproach.
OUPLING SYSTEMATIC POLYMORPHISM DISCOVERY WITH
N CELLA AND HAPLOTYPE APPROACHES. Rather than us-
ng HapMap “tagging” SNPs at NPY1R, we systematically
canned the locus for both common and unusual variants in
unctional gene regions (exons, UTRs, and promoter). This
pproach allowed us to associate novel variants in potentially
ctive regions with physiological traits in vivo, and then
ursue the role of such variants in reporter assays in cella
Figs. 5 and 6, Online Fig. 2). Haplotyping across the locus
hen allowed us to confirm that particular combinations of
romoter and 3=-UTR alleles (especially promoter A-585
nd 3=-UTR 1050G) achieved especially pronounced
ffects on BP in the population (Fig. 4).
AVEATS. First, although we conducted systematic poly-
orphism discovery in 4 diverse ethnic groups, our studies
n autonomic physiology and disease were conducted only
n subjects of European ancestry; whether the observed
arker-on-trait associations occur in other populations
wait testing.
False positive (type I) statistical errors may occur during
enetic associations, since the effects of multiple genetic
ariants may be evaluated on traits. First of all, we used
aplotype analysis, and achieved a genetic effect on popu-
ation BP (Fig. 4) without multiple testing. Second, we
pplied SNPSpD (29) to compute the effective number of
NPs tested and a new target alpha threshold; the modified
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September 1, 2009:944–54 NPY1R Gene Expression and Hypertensionlpha  0.028 was exceeded in our association tests. The
ffects of NPY1R variants on BP were confirmed in 2
ndependent samples (twin pairs and population BP ex-
remes). Ultimately, our mechanistic studies in cella (Figs. 5
nd 6, Online Fig. 2) lend plausibility to our results.
Finally, we found that NPY1R variants that decreased
ene expression in cella predicted increased BP in vivo.
ince the NPY system seems to exert opposite effects on BP
hen administered centrally versus peripherally (6), we have
roposed a model in which the central effects of NPY1R
olymorphism predominate on trait determination (Fig. 8).
owever, although the central effects of the NPY/NYP1R
ystem can be explored in experimental animals (6), we
annot directly test the central effects of NPY/NPY1R
ctivation in humans.
onclusions and Perspectives
ommon polymorphism occurs across the NPY1R locus,
ncluding variants in such active domains as the proximal
romoter and 3=-UTR (Fig. 1). Such genetic variation,
specially in the 3=-UTR, predicts interindividual variability
n early, pathogenic autonomic traits that are precursors to
evelopment of hypertension, such as baroreceptor dysfunc-
ion and exaggerated pressor responses to stress (Fig. 2).
PY1R variants in both the promoter and 3=-UTR interact
ynergistically to influence BP in the population. Promoter and
=-UTR variants were each functional during in cella luciferase
eporter assays; the 3=-UTR variant disrupted a microRNA
ecognition motif. In each case (promoter and 3=-UTR), the
ariant that decreases NPY1R expression in cella also increases
P in vivo. Since central and peripheral NPY seem to exert
irectionally opposite effects on BP (6), we present a
ypothetical mechanistic scheme (Fig. 8) that links these
vents in the most parsimonious longitudinal fashion.
hese results indicate novel pathophysiological links
etween NPY1R and blood pressure, and may provide
Concept:
Gene
Mechanism
Physiological traits
Disease trait
Neuropeptide Y type 1 receptor (NPY1R): 
Transcriptional/translational, physiological, and disease consequences 
of common genetic variation in the 3’-UTR and promoter
Application to NPY1R:
3’-UTR A+1050G   mRNA stability
Promoter A-585T   Transcription
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Figure 8 Neuropeptide Y Type 1 Receptor
Transcriptional/translational, physiological, and disease consequences of
common genetic variation in the 3=-UTR and promoter. Abbreviations as in Figure 1.ew strategies for understanding the mechanism, diag-
osis, and treatment of systemic hypertension.
eprint requests and correspondence: Dr. Daniel T. O’Connor,
epartment of Medicine, UCSD School of Medicine, 9500
ilman Drive, La Jolla, California 92093-0838. E-mail: doconnor@
csd.edu.
EFERENCES
1. O’Connor DT, Insel PA, Ziegler MG, et al. Heredity and the
autonomic nervous system in human hypertension. Curr Hypertens
Rep 2000;2:16–22.
2. Rao F, Zhang L, Wessel J, et al. Tyrosine hydroxylase, the rate-
limiting enzyme in catecholamine biosynthesis: discovery of common
human genetic variants governing transcription, autonomic activity,
and blood pressure in vivo. Circulation 2007;116:993–1006.
3. Takiyyuddin MA, Brown MR, Dinh TQ, et al. Sympatho-adrenal
secretion in humans: factors governing catecholamine and storage
vesicle peptide co-release. J Auton Pharmacol 1994;14:187–200.
4. az-Cabiale Z, Parrado C, Rivera A, et al. Galanin-neuropeptide Y
(NPY) interactions in central cardiovascular control: involvement of
the NPYY1 receptor subtype. Eur J Neurosci 2006;24:499–508.
5. Deltondo J, Por I, Hu W, et al. Associations between the human growth
hormone-releasing hormone- and neuropeptide-Y-immunoreactive sys-
tems in the human diencephalon: a possible morphological substrate of
the impact of stress on growth. Neuroscience 2008;153:1146–52.
6. Michalkiewicz M, Zhao GQ, Jia Z, Michalkiewicz T, Racadio MJ.
Central neuropeptide Y signaling ameliorates N(omega)-nitro-L-
arginine methyl ester hypertension in the rat through a Y1 receptor
mechanism. Hypertension 2005;45:780–5.
7. Zhou ZF, Zhu GS, Hariri AR, et al. Genetic variation in human
NPY expression affects stress response and emotion. Nature 2008;
452:997–1001.
8. Beck B, Max JP. Neuropeptide Y in the arcuato-paraventricular
pathway and diet selection in the vasopressin-deficient Brattleboro rat.
Brain Res Bull 2008;76:454–7.
9. Eva C, Serra M, Mele P, Panzica G, Oberto A. Physiology and gene
regulation of the brain NPY Y1 receptor. Front Neuroendocrinol
2006;27:308–39.
0. Kennedy B, Shen GH, Ziegler MG. Neuropeptide Y-mediated
pressor responses following high-frequency stimulation of the rat
sympathetic nervous system. J Pharmacol Exp Ther 1997;281:291–6.
1. Cavadas C, Cefai D, Rosmaninho-Salgado J, et al. Deletion of the
neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of
NPY on catecholamine synthesis and secretion. Proc Natl Acad Sci
USA 2006;103:10497–502.
2. O’Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara
N, Parmer RJ. Early decline in the catecholamine release-inhibitory
peptide catestatin in humans at genetic risk of hypertension. J Hyper-
tens 2002;20:1335–45.
3. Zhang L, Rao F, Wessel J, et al. Functional allelic heterogeneity and
pleiotropy of a repeat polymorphism in tyrosine hydroxylase: predic-
tion of catecholamines and response to stress in twins. Physiol
Genomics 2004;19:277–91.
4. Cockburn M, Hamilton A, Zadnick J, Cozen W, Mack TM. The
occurrence of chronic disease and other conditions in a large
population-based cohort of native Californian twins. Twin Res 2002;
5:460–7.
5. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Prevalence of
coronary heart disease associated with HFE mutations in adults
attending a health appraisal center. Am J Med 2002;113:472–9.
6. Schork NJ, Nath SK, Fallin D, Chakravarti A. Linkage disequilibrium
analysis of biallelic DNA markers, human quantitative trait loci, and
threshold-defined case and control subjects. Am J Hum Genet.
2000;67:1208–18.
7. Schork NJ. Power calculations for genetic association studies using
estimated probability distributions. Am J Hum Genet 2002;70:
1480–9.
11
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
K
F
954 Wang et al. JACC Vol. 54, No. 10, 2009
NPY1R Gene Expression and Hypertension September 1, 2009:944–548. Rana BK, Insel PA, Payne SH, et al. Population-based sample reveals
gene-gender interactions in blood pressure in White Americans.
Hypertension 2007;49:96–106.
9. Tenesa A, Knott SA, Carothers AD, Visscher PM. Power of linkage
disequilibrium mapping to detect a quantitative trait locus (QTL) in
selected samples of unrelated individuals. Ann Hum Genet 2003;67:
557–66.
0. Conen D, Bamberg F. Noninvasive 24-h ambulatory blood pressure
and cardiovascular disease: a systematic review and meta-analysis.
J Hypertens 2008;26:1290–9.
1. Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure
familial contributions to blood pressure variation. Hypertension 2003;
41:207–10.
2. Wu J, Kraja AT, Oberman A, et al. A summary of the effects of
antihypertensive medications on measured blood pressure. Am J
Hypertens 2005;18:935–42.
3. Herrmann V, Buscher R, Go MM, et al. Beta2-adrenergic receptor
polymorphisms at codon 16, cardiovascular phenotypes and essential
hypertension in whites and African Americans. Am J Hypertens
2000;13:1021–6.
4. Brinton TJ, Kailasam MT, Wu RA, et al. Arterial compliance by cuff
sphygmomanometer. Application to hypertension and early changes in
subjects at genetic risk. Hypertension 1996;28:599–603.
5. Rao F, Wen G, Gayen JR, et al. Catecholamine release-inhibitory
peptide catestatin (chromogranin A(352-372)): naturally occurring
amino acid variant Gly364Ser causes profound changes in human
autonomic activity and alters risk for hypertension. Circulation 2007;
115:2271–81.
6. Almasy L, Blangero J. Multipoint quantitative-trait likage analysis in
general pedigrees. Am J Hum Genet 1998;62:1198–211.
7. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and
visualization of LD and haplotype maps. Bioinformatics 2005;21:
263–5.
8. Zaitlen NA, Kang HM, Feolo ML, Sherry ST, Halperin E, Eskin E.
Inference and analysis of haplotypes from combined genotyping
studies deposited in dbSNP. Genome Res 2005;15:1594–600. F9. Nyholt DR. A simple correction for multiple testing for single-
nucleotide polymorphisms in linkage disequilibrium with each other.
Am J Hum Genet 2004;74:765–9.
0. Chen Y, Rao F, Das M, et al. Common, naturally occurring human
genetic variation in the 3=-untranslated region of the secretory protein
chromogranin A (CHGA) determines autonomic circulatory regulation
and hypertension. J Am Coll Cardiol 2008;52:1468–81.
1. Naveilhan P, Hassani H, Lucas G, et al. Reduced antinociception and
plasma extravasation in mice lacking a neuropeptide Y receptor.
Nature 2001;409:513–7.
2. Herzog H, Hort YJ, Ball HJ, Hayes G, Shine J, Selbie LA. Cloned
human neuropeptide Y receptor couples to two different second
messenger systems. Proc Natl Acad Sci USA 1992;89:5794–8.
3. Cavadas C, Waeber B, Pedrazzini T, et al. NPY Y1 receptor is not
involved in the hemodynamic response to an acute cold pressor test in
mice. Peptides 2007;28:315–9.
4. Sethupathy P, Borel C, Gagnebin M, et al. Human microRNA-155
on chromosome 21 differentially interacts with its polymorphic target
in the AGTR1 3= untranslated region: a mechanism for functional
single-nucleotide polymorphisms related to phenotypes. Am J Hum
Genet 2007;81:405–13.
5. Zhang L, Rao F, Zhang K, et al. Discovery of common human genetic
variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide,
autonomic activity, and cardiovascular risk. J Clin Invest 2007;117:
2658–71.
6. Boomsma D, Busjahn A, Peltonen L. Classical twin studies and
beyond. Nat Rev Genet 2002;3:872–82.
ey Words: hypertension y neuropeptide y genetics.
APPENDIX
or supplementary Tables 1 and 2 and supplementary
igures 1 to 4, please see the online version of this article.
